Physician profile
Mayela G Jackson
NPI 1912298175
$6,012.71
in general payments reported to CMS, 2019-2025
15 companies · $504 in 2025
The $504 reported for 2025 was more than what 77% of Acute Care (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $343 · 2022: $39.82 · 2023: $413 · 2024: $4,713 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,629.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $4,358.75 | 2024 | M22 |
| Abbvie INC. | $773.71 | 2023-2025 | |
| Merz North America, INC. | $343.77 | 2024-2025 | |
| Pacira Therapeutics, INC. | $271.93 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $52.71 | 2025 | |
| Depuy Synthes Sales INC. | $37.30 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $27.22 | 2025 | Exparel |
| Sanofi-Aventis U.S. LLC | $22.40 | 2021 | |
| Boston Scientific Corporation | $21.34 | 2025 | Latitude Communicator Power Supply |
| Ethicon US, LLC | $20.75 | 2023 | Stratafix, Dermabond Prineo, Monocryl |
| Bsn Medical INC | $18.67 | 2022 | |
| Smith+Nephew, INC. | $18.03 | 2021 | |
| Orthofix Medical, INC. | $17.14 | 2025 | Physio-Stim |
| Ferring Pharmaceuticals INC. | $14.56 | 2021 | |
| Davol INC. | $14.43 | 2024 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayela Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.